Molecular and Clinical Insights into the Invasive Capacity of Glioblastoma Cells

Area of Science:

• Neuro-oncology
• Cancer Biology
• Molecular Medicine

Background:

• Glioblastoma (GBM) exhibits invasive properties, correlating with treatment resistance, recurrence, and reduced patient survival.
• GBM invasiveness is governed by complex molecular pathways, including PI3K/Akt, Wnt, Hedgehog, and NFkB, interacting with the tumor microenvironment.
• Despite advances in understanding GBM invasion mechanisms, clinical translation remains limited, posing significant challenges in treatment and outcome prediction.

Purpose of the Study:

• To elucidate the molecular and cellular hallmarks of glioblastoma invasion.
• To highlight the clinical challenges associated with identifying and treating invasive GBM components.
• To bridge the gap between molecular understanding and clinical application for GBM invasion.

Main Methods:

• Review of molecular signaling pathways implicated in GBM invasion (PI3K/Akt, Wnt, Hedgehog, NFkB).
• Analysis of extracellular matrix and host cell interactions in GBM.
• Evaluation of current pre- and intraoperative methods for defining GBM tumor boundaries.
• Discussion of the clinical significance and impact of treating infiltrative GBM.

Main Results:

• Key signaling pathways (PI3K/Akt, Wnt, Hedgehog, NFkB) are central to GBM cellular invasion.
• Current methods for delineating invasive GBM are insufficient, complicating treatment strategies.
• The clinical impact of targeting infiltrative GBM remains poorly understood.

Conclusions:

• Targeting GBM invasion requires a deeper understanding of its molecular underpinnings.
• Improved diagnostic and therapeutic strategies are needed to address the clinical challenge of infiltrative GBM.
• Further research is essential to translate molecular insights into effective clinical interventions for GBM patients.